An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls

Since 2014, several countries have implemented a 2-dose schedule for Human papillomavirus (HPV) vaccination. Licensure of the 2-dose schedule was based on non-inferiority results from immunobridging studies, comparing the antibody levels of the 2-dose schedule in young girls to those of the 3-dose s...

Descripción completa

Detalles Bibliográficos
Autores principales: Donken, Robine, Bogaards, Johannes A., van der Klis, Fiona R. M., Meijer, Chris J. L. M., de Melker, Hester E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964747/
https://www.ncbi.nlm.nih.gov/pubmed/27171128
http://dx.doi.org/10.1080/21645515.2016.1160978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964747/
https://www.ncbi.nlm.nih.gov/pubmed/27171128
http://dx.doi.org/10.1080/21645515.2016.1160978

Ejemplares similares